Randomized, multifactorial, double-blind, parallel-group, dose-ranging study of the efficacy and safety of rituximab (MabThera/Rituxan) in combination with methotrexate in patients with active rheumatoid arthritis
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2014
At a glance
- Drugs Rituximab (Primary) ; Corticosteroids; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Genentech
- 23 Feb 2010 Additional locations identified as reported by Roche website.
- 27 Sep 2008 Planned end date changed to 1 Jun 2012.
- 27 Sep 2008 Updated official title.